HOME >> BIOLOGY >> NEWS
Highlights of American Chemical Society's national meeting in New Orleans

A "spice" that fights foodborne germs, vegetable oil for car engines, a vaccine to help smokers quit and chemical innovations to improve homeland security are among the topics to be covered at the national meeting of the world's largest scientific society in New Orleans, March 23-27.

NEW ORLEANS A record number of presentations, more than 8,500, are expected for the 225th national meeting of the American Chemical Society, the world's largest scientific society, in New Orleans, March 23-27. Research papers and posters will be presented at the Ernest N. Morial Convention Center, 900 Convention Center Boulevard, and surrounding hotels. The pressroom will be located in Room 280 of the convention center.

Highlights include:

  • Rechargeable batteries that operate on alcohol
  • Getting rid of termites with catnip
  • New class of nonaddictive painkillers that could be better than morphine
  • More efficient fridges and A/Cs with no moving parts
  • Contact lenses that dispense medicine
  • Cranberry juice increases levels of "good" cholesterol
  • Evolution of plants from sea to land: fossil evidence

News releases and advisories are posted on an embargoed basis, at www.eurekalert.org under the "ACS 225th National Meeting" button. They also will be posted at www.chemistry.org/news after the embargoes are lifted.

Sunday, March 23

Homeland security Advances in the development of sensors to detect chemical and biological warfare agents are among the topics that will be discussed during a one-day symposium entitled "Function-Based and Other Novel Approaches to Sensors for Homeland Defense." (ANYL 1-6, Sunday, March 9, 8:30 a.m.-11:40 a.m., Morial Convention Center, Room 384, and ANYL 13-
'"/>


26-Mar-2003


Page: 1 2 3 4 5

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
3. Highlights of the July Journal of the American Dietetic Association
4. Other Highlights in the June 2 JNCI
5. Highlights of Tufts University nutrition research: January 2004
6. Highlights of the November 2003 Journal of the American Dietetic Association
7. Highlights of the October 2003 Journal of the American Dietetic Association
8. Highlights of American Chemical Society meeting in New Orleans
9. Highlights of American Chemical Societys national meeting in Boston
10. Other Highlights in the July 3 Issue of JNCI
11. Quarterly News Tipsheet -- Research Highlights From Pacific Northwest National Laboratory

Post Your Comments:
(Date:3/11/2015)... , March 11, 2015   The ... its platform to scientifically measure and harness music ... to real-time biometrics and objective measurements of physiology, ... music at scale in large populations. It is ... technologists and clinicians perform rigorous studies and accelerate ...
(Date:3/10/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ... biometric authentication company focused on the growing mobile ... has been named the "Number One Best Tech ... Rethink Modern ( http://www.rethinkmodern.com/ ) is a web ... and lifestyle that have a unique function or design.  ...
(Date:3/2/2015)... SAN JOSE, Calif. , March 2, 2015 ... ), the leading developer of human interface solutions, ... ID technology that is designed to enable rapid ... Synaptics Natural ID™ module for gaming is a ... and ODMs the ability to quickly integrate fingerprint ...
Breaking Biology News(10 mins):Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
(Date:3/30/2015)... , March 30, 2015 CASI Pharmaceuticals, Inc. ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a commercial focus on China ... Drug Administration (CFDA) has approved the Company,s application to ... clear cell carcinoma (OCCC) patients for its proprietary drug ...
(Date:3/30/2015)... GERMANTOWN, Md. , March 30, 2015  /PRNewswire/ ... a leader in synthetic biology, and Merck Serono, ... Germany , today announced an exclusive ... commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. ... to develop innovative therapies that modulate the immune ...
(Date:3/30/2015)... Washington, USA (PRWEB) March 29, 2015 ... and the United States and plenary talks by four ... SPIE Optics + Optoelectronics next month in ... technical presentations in 17 conferences alongside a two-day exhibition. ... and photonics , the event will run 13-16 April ...
(Date:3/30/2015)... 2015  Naldemedine, an investigational peripherally acting mu-opioid ... Co., Ltd., met its primary and secondary endpoints ... the treatment of opioid-induced constipation (OIC) in adult ... Study results showed that naldemedine (0.2 mg tablet ... of spontaneous bowel movement (SBM) compared with placebo ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: